The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients

The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients

Brief description of study

The research study is being conducted secondary and after your completion of the primary study (Effect of Radiation Therapy on Sleepiness and Activity in Prostate and Breast Cancer Patients). The purpose of the current study is to assess the effectiveness of a behavioral treatment for insomnia (also known as Cognitive Behavioral Therapy for Insomnia) on both insomnia and cancer-related pre and post Radiation Therapy. Information from the primary study will be used in conjunction with the data from this study to see if there are changes in your sleepiness and fatigue. Information that will be used includes study questionnaires, sleep study and FMRI data and blood draw information.
 
Cognitive Behavioral Therapy for Insomnia (CBT-I) has been shown to be an effective treatment for insomnia in both cancer and non-cancer populations. However, CBT-I has yet to demonstrate an effect on cancer-related fatigue. This study aims to see whether an increased amount of CBT-I sessions decreases the amount of fatigue that you may be experiencing.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    prostate cancer,men's health
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 21 Feb 2020. Study ID: 834620

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center